[Form 3] Conexeu Sciences Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Conexeu Sciences Inc. director Ana Lucia Bastiani-Posner reported her initial holdings of stock options. She holds options to buy 50,000 shares of common stock at an exercise price of $2.30 per share, expiring on February 9, 2031.

The footnote explains these options were granted on February 9, 2026 and vest over 12 months, with 25% of the grant vesting at three, six, nine and twelve months from the grant date. This filing is a baseline disclosure of her derivative equity position rather than a new market transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Bastiani-Posner Ana Lucia

Role null

Type	Security	Shares	Price	Value
holding	Option (right to buy)	--	--	--

Holdings After Transaction: Option (right to buy) — 50,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/23/2026 - 09:52 PM Accepted by SEC EDGAR 06/23/2026 - 09:51 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bastiani-Posner Ana Lucia

(Last) (First) (Middle)

50 WEST LIBERTY STREET, SUITE 880

(Street)

RENO NEVADA 89501

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/15/2026

3. Issuer Name and Ticker or Trading Symbol
Conexeu Sciences Inc. [ CNXU ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	(1)	02/09/2031	Common Stock	50,000	$2.3	D

Explanation of Responses:

1. Represents options to purchase shares of common stock that were granted on February 9, 2026 and vest over a 12-month period (25% three, six, nine and twelve months from the date of grant).

	/s/ Ana Bastiani-Posner	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)